ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell, I. M.
Right arrow Articles by Logan, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, I. M.
Right arrow Articles by Logan, R. W.

The Annals of Thoracic Surgery, Vol 52, 1138-1140, Copyright © 1991 by The Society of Thoracic Surgeons


ARTICLES

Transcutaneous iodine absorption in infants undergoing cardiac operation

IM Mitchell, JC Pollock, MP Jamieson, KC Fitzpatrick and RW Logan
Department of Cardiac Surgery, Royal Hospital for Sick Children, Yorkhill, Glasgow, Scotland.

Povidone-iodine is an effective antiseptic, but its topical use has been associated with a number of adverse reactions in burn patients and in neonates as a result of transcutaneous absorption. In particular, high plasma iodine concentrations are known to cause renal failure, metabolic acidosis, and thyroid suppression. Because of the permeable nature of the skin in small infants and the large areas cleaned before cardiac operations, it is possible that significant transcutaneous iodine absorption might occur in this situation. We have studied 17 infants, less than 3 months of age, who were undergoing closed cardiac or thoracic procedures. After povidone-iodine skin preparation in 15 (covering 20% to 30% of body surface area), plasma total iodine concentrations rose fourfold (range, 160% to 1,440%). This increase was significantly different from the preoperative level at 6, 12, 18, and 24 hours. There was no increase in plasma iodine concentration in 2 patients who were not exposed to povidone-iodine or any other iodine- containing compound. We discuss the implications for a topical antisepsis policy in infants.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. S. Mackie, K. L. Booth, J. W. Newburger, K. Gauvreau, S. A. Huang, P. C. Laussen, J. A. DiNardo, P. J. del Nido, J. E. Mayer Jr, R. A. Jonas, et al.
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 810 - 816.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. J. Mancini
Skin
Pediatrics, April 1, 2004; 113(4/S1): 1114 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. Kovacikova, P. Kunovsky, P. Skrak, V. Hraska, L. Kostalova, and E. Tomeckova
Thyroid hormone metabolism in pediatric cardiac patients treated by continuous povidone-iodine irrigation for deep sternal wound infection
Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 1037 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
N Linder, B Sela, B German, N Davidovitch, J Kuint, J Hegesh, D Lubin, and J Sack
Iodine and hypothyroidism in neonates with congenital heart disease
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 1997; 77(3): 239F - 240.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
I. M. Mitchell, R. D. Mainwaring, J. J. Lamberti, and J. C. Nelson
Thyroid Function After Cardiopulmonary Bypass in Neonates
Ann. Thorac. Surg., September 1, 1995; 60(3): 745 - 747.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.